• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Accenture & League Partner to Transform Digital Healthcare Experiences

by Jasmine Pennic 02/15/2022 Leave a Comment

Accenture and League Partner to Transform Digital Healthcare Experiences

What You Should Know: - Accenture and League, a health-focused platform-as-a-service company, are collaborating to create experiences and increase access to improve outcomes for people, providers, payers, and retail pharmacies. - As part of the collaboration that combines Accenture’s data analytics and systems integration capabilities with League’s healthcare experience platform, the two companies will scale platform implementations and innovations to create personalized digital healthcare
Read More

LifeSpeak To Acquire Wellbeats for up to $92.5M

by Fred Pennic 02/14/2022 Leave a Comment

LifeSpeak To Acquire Wellbeats for up to $92.5M

What You Should Know: - LifeSpeak Inc. (TSX: LSPK), today announced it will acquire Wellbeats Inc., an on-demand physical well-being platform, for up to $92.5M USD. As the leader in mental health and total wellbeing for employers, this acquisition enables LifeSpeak to meet the rapidly growing demand for a comprehensive, single-vendor solution that addresses both mental and physical health support needs. - Wellbeats, a Minnesota-based market-leading provider of an on-demand,
Read More

Variantyx Secures $41.5M for Genetic Testing and Personalized Medicine

by Fred Pennic 02/14/2022 Leave a Comment

Variantyx Secures $41.5M for Genetic Testing and Personalized Medicine

What You Should Know: - Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, today announced they have secured $41.5M in C-2 funding led by New Era Capital Partners and includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners, and Pitango HealthTech. - Founded in 2014, the Variantyx proprietary whole genome sequencing and analysis
Read More

Respira Labs Secures $2.8M to Expand Clinical-Grade Respiratory Health Wearable

by Jasmine Pennic 02/10/2022 Leave a Comment

Respira Labs Secures $2.8M to Expand Clinical-Grade Respiratory Health Wearable

What You Should Know: - Respira Labs, a Latina-led medical technology company specializing in respiratory care, today announces it has closed $2.8M to continue to develop and produce its clinical-grade respiratoryhealth wearable that uses acoustic resonance to assess lung function and identify changes in lung air volume, which is especially critical for COPD, COVID-19 and asthma patients. - Respira Labs raised $1 million in pre-seed funding led by Zentynel Frontier Investments with
Read More

LifeOmic Acquires Bavard, an Enterprise-Grade Conversational AI Platform

by Fred Pennic 02/10/2022 Leave a Comment

LifeOmic Acquires Bavard, an Enterprise-Grade Conversational AI Platform

What You Should Know: - LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power precision health and wellness solutions announced it has acquired Bavard, a Utah-based conversational artificial intelligence (AI) company offering intelligent digital assistants and platforms. Financial details of the acquisition were not disclosed. - The acquisition comes as AI technology has experienced widespread adoption in the health care space, a trend
Read More

Scopio Secures $50M for AI-Powered Peripheral Blood Smear App

by Fred Pennic 02/09/2022 Leave a Comment

Scopio Secures $50M for AI-Powered Peripheral Blood Smear App

What You Should Know: - Scopio Labs, provider of the world's first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples. - The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic investors operating in the field and existing
Read More

Amazon Care Expands Telehealth Services Nationwide, Expands In-Person Services in More Than 20 Cities

by Fred Pennic 02/08/2022 Leave a Comment

Amazon Care Expands Telehealth Services Nationwide, Expands In-Person Services in More Than 20 Cities

What You Should Know: - Amazon Care expands its telehealth services nationwide and in-person services will be rolled out in more than 20 new cities this year. The service is already available in Seattle, Baltimore, Boston, Dallas, Austin, Los Angeles, Washington, D.C., and Arlington. - Amazon plans to expand more than 20 additional cities—including major metropolitan areas like San Francisco, Miami, Chicago, and New York City—so customers can access care where and when they need it
Read More

Medable Launches Decentralized Clinical Trials Partner Network

by Fred Pennic 02/08/2022 Leave a Comment

Medable Launches Decentralized Clinical Trials Partner Network

What You Should Know: - Medable Inc., a Palo Alto, CA-based provider for patient-centered clinical trials, today launched the Medable Partner Network – uniting a diverse ecosystem of technology, service, data, site, and direct-to-patient partners that work together to accelerate deployment of decentralized clinical trials. - The network includes new partnerships with Advanced Clinical, Cognizant, and CVS, and expanded relationships with Datavant, Oracle, Parexel, PPD, part of
Read More

Lucira Health Secures $80M to Expand COVID-19 Test Kit

by Fred Pennic 02/08/2022 Leave a Comment

Lucira Health Secures $80M to Expand COVID-19 Test Kit

What You Should Know: - Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced it has secured a debt facility of up to $80M with Hercules Capital, Inc. and Silicon Valley Bank. - Lucira's COVID-19 testing platform produces lab-quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. The FDA EUA
Read More

C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials

by Jasmine Pennic 02/08/2022 Leave a Comment

Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative to Advance Precision Cancer Treatment

What You Should Know: - Today, Twist Bioscience and cancer genomics startup C2i Genomics announced a partnership to develop whole-genome cancer reference materials. - This resource will provide diagnostic labs around the globe with the ability to better validate and monitor the quality of their whole-genome cancer screening and minimal residual disease (MRD) products for more accurate cancer detection.  C2i to integrate Twist’s library preparation kits into minimal residual
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 339
  • Go to page 340
  • Go to page 341
  • Go to page 342
  • Go to page 343
  • Interim pages omitted …
  • Go to page 730
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |